Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

In 2024, Xavier Montalban and colleagues 6 reported results from two phase 3 trials of the oral BTK inhibitor evobrutinib, which was compared with the approved drug teriflunomide in participants with ...

Thinning and loss of retinal vessels is evident in eyes of patients with multiple sclerosis (MS) and might be associated ... with MS. Our findings provide novel insights into the retinal pathology ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...